Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 2)
Volume: 22 Issue: 34
Author(s): Subhash C. Basak, Anuraj Nayarisseri, Humberto González-Díaz and Danail Bonchev
Affiliation:
Export Options
About this article
Cite this article as:
Basak C. Subhash, Nayarisseri Anuraj, González-Díaz Humberto and Bonchev Danail, Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 2), Current Pharmaceutical Design 2016; 22 (34) . https://dx.doi.org/10.2174/138161282234161110222751
DOI https://dx.doi.org/10.2174/138161282234161110222751 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance
Current Cancer Drug Targets Scalarane Sesterterpenoids
Current Bioactive Compounds Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases
Current Drug Safety The PA207 Peptide Inhibitor of LIM-only Protein 2 (Lmo2) Targets Zinc Finger Domains in a Non-specific Manner
Protein & Peptide Letters Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry Nano-Enabled Drug Delivery in Cancer Therapy: Literature Analysis Using the MeSH System
Pharmaceutical Nanotechnology Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery
Current Pharmaceutical Design ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases
Central Nervous System Agents in Medicinal Chemistry Nitrosative Stress as a Mediator of Apoptosis: Implications for Cancer Therapy
Current Pharmaceutical Design Gold Nanostructure: Fabrication, Surface Modification, Targeting Imaging, and Enhanced Radiotherapy
Current Nanoscience Reynoutria Japonica from Traditional Chinese Medicine: A Source of Competitive Adenosine Deaminase Inhibitors for Anticancer
Combinatorial Chemistry & High Throughput Screening Cyclooxygenase-2 Inhibition and Gastric Cancer
Current Pharmaceutical Design Drug Discovery in Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Retinoic Acid Metabolism and Mechanism of Action: A Review
Current Drug Metabolism Resveratrol: A New Potential Therapeutic Agent for Melanoma?
Current Medicinal Chemistry Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides
Current Radiopharmaceuticals Peptides as Drugs: From Screening to Application
Current Pharmaceutical Biotechnology Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets